Theratechnologies (NASDAQ:THTX) Posts Quarterly Earnings Results

Theratechnologies (NASDAQ:THTX) issued its quarterly earnings data on Wednesday. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.04, Yahoo Finance reports. The company had revenue of $22.02 million for the quarter. During the same quarter last year, the business earned ($0.40) earnings per share. Theratechnologies updated its FY 2024 guidance to EPS.

Theratechnologies Price Performance

Shares of NASDAQ:THTX opened at $1.45 on Friday. Theratechnologies has a one year low of $0.88 and a one year high of $3.60. The firm has a fifty day moving average price of $1.30 and a two-hundred day moving average price of $1.47.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.